{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T19:12:13Z","timestamp":1780341133853,"version":"3.54.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"16","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"name":"Institute of Medical Science"},{"DOI":"10.13039\/501100004721","name":"University of Tokyo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004721","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.bmcl.2019.06.050","type":"journal-article","created":{"date-parts":[[2019,6,26]],"date-time":"2019-06-26T23:40:27Z","timestamp":1561592427000},"page":"2162-2167","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Minimum structural requirements for inhibitors of the zinc finger protein TRAF6"],"prefix":"10.1016","volume":"29","author":[{"given":"Mohamed O.","family":"Radwan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryoko","family":"Koga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Hida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiko","family":"Ejima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Kanemaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Tateishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinari","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-ichiro","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikako","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masami","family":"Otsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2019.06.050_b0005","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1146\/annurev.bi.61.070192.004341","article-title":"Zinc proteins: enzymes, storage proteins, transcription factors, and replication proteins","volume":"61","author":"Coleman","year":"1992","journal-title":"Annu Rev Biochem"},{"issue":"12","key":"10.1016\/j.bmcl.2019.06.050_b0010","first-page":"2298","article-title":"Structure and stability of an unusual zinc-binding protein from Bacteroides thetaiotaomicron","volume":"1844","author":"Knaus","year":"2014","journal-title":"BBA"},{"issue":"9","key":"10.1016\/j.bmcl.2019.06.050_b0015","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/pro.2501","article-title":"The role of zinc in the stability of the marginally stable IscU scaffold protein","volume":"23","author":"Iannuzzi","year":"2014","journal-title":"Protein Sci"},{"issue":"2","key":"10.1016\/j.bmcl.2019.06.050_b0020","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1099\/jgv.0.000701","article-title":"Zinc-binding site of human immunodeficiency virus 2 Vpx prevents instability and dysfunction of the protein","volume":"98","author":"Yamamoto","year":"2017","journal-title":"J Gen Virol"},{"issue":"1","key":"10.1016\/j.bmcl.2019.06.050_b0025","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/2211-5463.12358","article-title":"Introduction of H2C2-type zinc-binding residues into HIV-2 Vpr increases its expression level","volume":"8","author":"Koga","year":"2018","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.bmcl.2019.06.050_b0030","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/978-0-387-70630-6_6","article-title":"Characteristics and biological functions of TRAF6","volume":"597","author":"Inoue","year":"2007","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"10.1016\/j.bmcl.2019.06.050_b0035","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/imr.12302","article-title":"Tumor necrosis factor receptor- associated factor 6 (TRAF6) regulation of development, function, and homeostasis of the immune system","volume":"266","author":"Walsh","year":"2015","journal-title":"Immunol Rev"},{"issue":"2","key":"10.1016\/j.bmcl.2019.06.050_b0040","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0092-8674(00)00126-4","article-title":"Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain","volume":"103","author":"Deng","year":"2000","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.bmcl.2019.06.050_b0045","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S1097-2765(04)00236-9","article-title":"The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes","volume":"14","author":"Sun","year":"2004","journal-title":"Mol Cell"},{"issue":"93","key":"10.1016\/j.bmcl.2019.06.050_b0050","doi-asserted-by":"crossref","first-page":"ra66","DOI":"10.1126\/scisignal.2000387","article-title":"Two mechanistically and temporally distinct NF-kappaB activation pathways in IL-1 signaling","volume":"2","author":"Yamazaki","year":"2009","journal-title":"Sci Signal."},{"issue":"36","key":"10.1016\/j.bmcl.2019.06.050_b0055","doi-asserted-by":"crossref","first-page":"24871","DOI":"10.1074\/jbc.M802749200","article-title":"The RING domain and first zinc finger of TRAF6 coordinate signaling by interleukin-1, lipopolysaccharide, and RANKL","volume":"283","author":"Lamothe","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bmcl.2019.06.050_b0060","series-title":"Drug design of zinc-enzyme inhibitors: functional, structural, and disease applications","year":"2009"},{"issue":"10","key":"10.1016\/j.bmcl.2019.06.050_b0065","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1038\/13423","article-title":"Design of angiotensin converting enzyme inhibitors","volume":"5","author":"Cushman","year":"1999","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.bmcl.2019.06.050_b0070","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1021\/jm950831t","article-title":"Metal-chelating inhibitors of a zinc finger protein HIV-EP1. Remarkable potentiation of inhibitory activity by introduction of SH groups","volume":"39","author":"Fujita","year":"1996","journal-title":"J Med Chem"},{"issue":"1","key":"10.1016\/j.bmcl.2019.06.050_b0075","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0968-0896(96)00203-9","article-title":"Synthetic inhibitors of regulatory proteins involved in the signaling pathway of the replication of human immunodeficiency virus 1","volume":"5","author":"Otsuka","year":"1997","journal-title":"Bioorg Med Chem"},{"issue":"4","key":"10.1016\/j.bmcl.2019.06.050_b0080","first-page":"613","article-title":"An anti-HIV-1 compound that increases steady-state expression of apoplipoprotein B mRNA-editing enzyme-catalytic polypeptide-like 3G","volume":"28","author":"Ejima","year":"2011","journal-title":"Int J Mol Med"},{"issue":"18","key":"10.1016\/j.bmcl.2019.06.050_b0085","doi-asserted-by":"crossref","first-page":"4398","DOI":"10.1016\/j.bmc.2016.07.030","article-title":"Zinc-mediated binding of a low-molecular-weight stabilizer of the host anti-viral factor apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3G","volume":"24","author":"Radwan","year":"2016","journal-title":"Bioorg Med Chem"},{"issue":"23","key":"10.1016\/j.bmcl.2019.06.050_b0090","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1002\/cmdc.201700399","article-title":"A dithiol compound binds to the zinc finger protein TRAF6 and suppresses its ubiquitination","volume":"12","author":"Koga","year":"2017","journal-title":"ChemMedChem"},{"issue":"7","key":"10.1016\/j.bmcl.2019.06.050_b0095","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1590\/S0103-50532006000700011","article-title":"Synthesis and characterization of platinum(II) complexes from trifluoromethyl phenylenediamine, picoline and N-benzyl ethylenediamine derivatives","volume":"17","author":"De Almeida","year":"2006","journal-title":"J Braz Chem Soc"},{"issue":"1","key":"10.1016\/j.bmcl.2019.06.050_b0100","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ica.2010.09.002","article-title":"Spectroscopic differences between heterocyclic benzothiazoline, -thiazole and imine containing ligands and comparison of the Co and Cu pyridine benzothiazole and imine complexes","volume":"365","author":"Carlson","year":"2011","journal-title":"Inorg Chim Acta"},{"issue":"4","key":"10.1016\/j.bmcl.2019.06.050_b0105","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/cber.19961290412","article-title":"Zinc complexes of the N, N, S ligand (mercaptophenyl)(picolyl)amine","volume":"129","author":"Brand","year":"1996","journal-title":"Chem Ber"},{"issue":"16","key":"10.1016\/j.bmcl.2019.06.050_b0110","doi-asserted-by":"crossref","first-page":"3862","DOI":"10.1016\/j.bmcl.2017.06.047","article-title":"A novel inhibitor of farnesyltransferase with a zinc site recognition moiety and a farnesyl group","volume":"27","author":"Tanaka","year":"2017","journal-title":"Bioorg Med Chem Lett"},{"issue":"12","key":"10.1016\/j.bmcl.2019.06.050_b0115","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1248\/cpb.59.1555","article-title":"An artificial copper complex incorporating a cell-penetrating peptide inhibits nuclear factor-kappaB (NF-kappaB) activation","volume":"59","author":"Kanemaru","year":"2011","journal-title":"Chem Pharm Bull"},{"issue":"9","key":"10.1016\/j.bmcl.2019.06.050_b0120","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/S0960-894X(03)00183-5","article-title":"A novel metal-chelating inhibitor of protein farnesyltransferase","volume":"13","author":"Hamasaki","year":"2003","journal-title":"Bioorg Med Chem Lett"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X19304329?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X19304329?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:29:20Z","timestamp":1760772560000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X19304329"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":24,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S0960894X19304329"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2019.06.050","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Minimum structural requirements for inhibitors of the zinc finger protein TRAF6","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2019.06.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}